印度医学影像市场评估：依产品、依应用、依最终用户、依地区、机会和预测（2018年度-2032年度）

印度医学影像市场规模预计将从2024年度的16.4846亿美元增至2032年度的36.2224亿美元，预计在2025年度至2032年度的预测期内年复合成长率为 10.34%。该市场的推动因素包括政府举措和资金、人口老化和相关慢性病的成长、先进技术系统的日益采用、医疗保健的普及、数位健康解决方案的整合、健康意识的提高以及策略的推动。包括策略伙伴关係和改进的偿付政策。这些因素结合起来增加了对先进影像处理技术的需求，提高了可近性，并推动了市场的动态成长和发展。

医学影像透过提供支持准确诊断和有效治疗计划的详细内部影像，在医疗保健中发挥重要作用。促进疾病的早期发现、及时介入并显着改善患者的治疗效果。此外，医学影像在追踪疾病进展和评估治疗效果方面发挥着重要作用，可以做出必要的改变。医疗影像市场受到技术进步的推动，这些技术的发展使得 CT 和磁振造影（MRI）等高品质影像得以发展，使医生能够做出更准确的诊断。此外，许多已开发国家，特别是低收入新兴经济体，医院支出的增加和先进影像技术的可用性也推动了对医疗设备的需求。

例如，2024年 5月，Fischer Medical Ventures Ltd.（FMVL）宣布成为印度第一家在国内生产 MRI 系统的公司，目的是减少对进口设备的依赖。该公司在印度维沙卡帕特南的Andhra Pradesh MedTech Zone（AMTZ）经营 MRI 製造业务。目前，印度医疗器材产业高度依赖进口，估计80-85%的设备来自美国、欧洲和中国。

本报告研究和分析了印度医学影像市场，提供市场规模和预测、市场动态以及主要参与者的状况。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 印度医学影像市场展望（2018-2032财政年度）

• 市场规模分析与预测
  • 金额
  • 数量
• 市占率分析与预测
  • 依产品
  • 依用途
  • 依最终用户
  • 依地区
  • 市占率分析：依公司（价值）（前5名公司及其他 -2024年度）
• 市场地图分析（2024年）
  • 依产品
  • 依用途
  • 依最终用户
  • 依地区

第5章 供需分析

第6章 进出口分析

第7章 价值链分析

第8章 波特五力分析

第9章 PESTLE分析

第10章 价格分析

第11章 市场动态

• 市场驱动因素
• 市场挑战

第12章 市场趋势与发展

第13章 监理架构与创新

• 监理机关的核准

第14章 专利状况

第15章 个案研究

第16章 竞争态势

• 前5名市场领导者的竞争矩阵
• 前5名的公司的SWOT 分析
• 市场前10名企业主要企业状况
  • Wipro GE Healthcare Pvt. Ltd.
  • Siemens Healthcare Private Limited
  • Philips India Limited
  • Toshiba Medical Systems India Pvt. Ltd.
  • Hitachi Healthcare Manufacturing Ltd.
  • Mindray Medical India Pvt. Ltd.
  • Fujifilm India Pvt. Ltd.
  • Hologic India Pvt. Ltd.
  • Shanghai United Imaging Healthcare Co., LTD.
  • Agfa Healthcare India Pvt. Ltd.

第17章 策略建议

第18章 关于本公司，免责声明

India medical imaging market is projected to witness a CAGR of 10.34% during the forecast period FY2025-FY2032F, growing from USD 1,648.46 million in FY2024 to USD 3,622.24 million in FY2032. India medical imaging market is driven by several factors, which include government initiatives and funding, the growing geriatric population and subsequent rise in chronic diseases, increased adoption of technologically advanced systems, expanded healthcare access, integration of digital health solutions, growing healthcare awareness, strategic partnerships, and improved reimbursement policies. These factors collectively enhance the demand for advanced imaging technologies and improve accessibility, driving the dynamic growth and evolution of the market.

Medical imaging plays an essential role in healthcare by providing detailed internal images that support accurate diagnosis and effective treatment planning. It facilitates early detection of diseases, allowing for timely intervention and significantly improving patient outcomes. Moreover, medical imaging plays a crucial role in tracking how a disease develops and in evaluating how well treatments work, allowing for needed changes. Technological advancements have enabled the development of high-quality images such as CT and magnetic resonance imaging (MRI) that help doctors make better diagnoses, hence driving the medical imaging market. Furthermore, an increase in hospital expenditure and availability of advanced imaging technologies across many developed nations predominately among lower income developing economies would also fuel the demand for health equipment.

For instance, in May 2024, Fischer Medical Ventures Ltd. (FMVL) announced that it had become the first company in India to manufacture MRI systems domestically, aiming to reduce the country's reliance on imported devices. The company is developing its MRI manufacturing in the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam, India. Currently, the Indian medical device industry is heavily dependent on imports, with estimates indicating that 80-85% of devices are sourced from the United States, Europe, and China.

Increased Adoption of Technologically Advanced Systems

The expansion of India medical imaging market is primarily driven by the adoption of technologically advanced medical imaging systems. Combining 3D imaging with improved contemporary diagnosis tools, including high-resolution MRI and PET scans. Growing health consciousness in the population regarding early diagnosis and preventive care is likewise adding to the increasing necessity for cutting-edge imaging strategies. As technology becomes less expensive, an increasing number of healthcare providers can incorporate these advanced systems into their practices. The integration of AI-powered imaging solutions is transforming patient treatment as they provide more accurate analysis and predictive insights, which, in turn, improve patient outcomes. Further, the rapid shift towards telemedicine and remote diagnostic services is making advanced imaging technologies more accessible, especially to patients in rural and underserved communities. Cumulatively, these are propelling the growth of the Indian medical imaging market.

For instance, in July 2024, Philips India Limited, along with Star Imaging and Research Center, launched the country's first MRI training school. This partnership aims to provide world-class training in MRI modalities for 17 different sub-specialties focusing on the practical approach of imaging as per international standards.

Growing Geriatric Population and Subsequent Rise in Chronic Disease

Rising prevalence of chronic diseases is one of the key drivers in the medical imaging market in India. Moreover, there is a rising burden of chronic diseases that would necessitate further monitoring and follow-ups, thus increasing imaging demand. The prevalence of diseases including cardiovascular disorders, cancer, and diabetes is high, with a demographic shift towards the aging population, which mandates the use of advanced imaging equipment for effective diagnosis. Chronic disease diagnosis, detection, and evaluation requirements lead to more use of medical imaging equipment, such as MRI scanning systems, CT scan equipment systems, and ultrasound systems.

India is witnessing a major demographic change. As per the data published by NITI Aayog Government of India, the population aged 60 and above is projected to reach 158.7 million by 2025, making up 11.1% of the total population, and is projected to reach 19.5% of the total population by 2050. This swift growth presents a significant health challenge. Social-economic factors influence the likelihood of chronic conditions among older adults. Older adults with high educational attainment, urban residence status (i.e., living in an urban area), direct economic dependence, and lack of a spouse or children remain most at risk for chronic conditions, as well as those from higher-income families.

For instance, multimorbidity defined as the presence of two or more chronic conditions in an individual, is on the rise among the elderly in India. The Longitudinal Ageing Study of India (LASI) found that approximately 23% of the elderly population has multi-morbidities, with women being more likely to suffer from these conditions than men.

Oncology Segment Leads the Market Share in India Medical Imaging Market

Oncology is one of the key contributors to the India medical imaging market, supported by high cancer cases requiring advanced medical imaging, such as PET-CT, MRI and radiography. Government investments in healthcare infrastructure support the adoption of these technologies. India is facing a concerning rise in cancer cases, outpacing global averages and earning the troubling title of the "cancer capital of the world." A looming healthcare crisis further complicates this increase, as conditions like pre-diabetes, pre-hypertension, and mental health issues are increasingly being diagnosed among younger populations. For women, the most common cancers include breast, cervical, and ovarian cancers, while men are primarily affected by lung, mouth, and prostate cancers. A major concern is the significantly lower median age for cancer diagnosis in India compared to other nations, which emphasizes the urgent need for better early detection methods. The country, however, offers limited cancer screening services despite the high incidence rates, reflecting a significant gap in an important aspect of healthcare that needs to be addressed urgently.

For instance, according to the Health of Nation report published by Apollo Hospital in 2024, new cases of cancer are expected to increase faster than global averages, from 1.39 million in 2020 to an estimated 1.57 million by the end of 2024. In India, 40% of cases occur due to tobacco use, which increases the risk for lung, oral, and throat cancers, poor diet, and infrequent physical activity account for only 10%.

Northern India Dominates the India Medical Imaging Market

North India has become a favorable growth-boosting region due to numerous factors that contribute positively to the medical imaging market. Rising cases of chronic diseases and cancer, along with the development of urban localities, facilitate the demand for better diagnostic capabilities. Top cities like Delhi, Mumbai, and Chandigarh are enhancing medical services by adopting high-resolution MRI, CT scans, and PET scans in numerous hospitals and diagnostic centers. Moreover, the substantial investment in healthcare infrastructure development and modernization has been a boon for North India, with government and private players contributing actively. Telemedicine and remote diagnostic services are also gaining ground as they bring advanced imaging solutions to rural or underserved regions. Furthermore, the focus of many medical research institutes and educational centers in North India, such as AIIMS, New Delhi, encourages innovation.

For instance, in August 2023, Voxelgrids Innovations Pvt. Ltd. introduced an ultrafast 1.5 Tesla high field strength MRI system under the National Biopharma Mission of the Department of Biotechnology. This cutting-edge product is cost-effective and signals the next generation of selling magnetic resonance technology in India.

Future Market Scenario (FY2025-FY2032F)

The outlook for India medical imaging market is highly optimistic, fueled by several key factors that are expected to drive substantial growth. Currently, there is an annual demand for less than 350 MRI machines, but with rising healthcare awareness and government initiatives like Ayushman Bharat aimed at improving access and inclusivity, this demand is projected to become more than double by 2030. This surge is anticipated to significantly reduce MRI scanning costs for the general population while decreasing reliance on imported devices, thereby saving substantial foreign exchange.

For instance, in August 2024, the Government of India launched the Phased Manufacturing Programme (PMP), through which it offered a 20% capital subsidy for the domestic production of CT scans, digital X-rays, and MRI machines. This highlights the country's move towards domestic innovation and manufacturing. Collectively, these advancements and policies are set to drive the expansion of the medical imaging market in India, enhancing both accessibility and affordability.

Key Players Landscape and Outlook

India medical imaging market is quite competitive, with a major number of players at local levels as well. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.

In June 2024, Fujifilm India's healthcare division, in partnership with NM Medical Mumbai, inaugurated its inaugural Fujifilm Skill Lab. This facility is dedicated to offering advanced training in full-field digital mammography (FFDM) technologies for radiologists and radiographers. The Fujifilm Mammography Skill Development Program aims to equip these professionals with the expertise needed to enhance their diagnostic capabilities and deliver superior patient care using Fujifilm's state-of-the-art mammography equipment.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Medical Imaging Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. X-ray Devices
      • 4.2.1.1.1. Radiography
      • 4.2.1.1.2. Fluoroscopy
      • 4.2.1.1.3. Mammography
    • 4.2.1.2. Ultrasound
      • 4.2.1.2.1. Handheld
      • 4.2.1.2.2. Compact
    • 4.2.1.3. Computed Tomography (CT)
      • 4.2.1.3.1. High-End Slice CT
      • 4.2.1.3.2. Mid-End Slice CT
      • 4.2.1.3.3. Low-End Slice CT
      • 4.2.1.3.4. Cone Beam CT
    • 4.2.1.4. Magnetic Resonance Imaging (MRI)
      • 4.2.1.4.1. Closed System
      • 4.2.1.4.2. Open System
    • 4.2.1.5. Nuclear Imaging
      • 4.2.1.5.1. SPECT
      • 4.2.1.5.2. PET
  • 4.2.2. By Application
    • 4.2.2.1. Cardiology
    • 4.2.2.2. Oncology
    • 4.2.2.3. Neurology
    • 4.2.2.4. Orthopedics
    • 4.2.2.5. Gastroenterology
    • 4.2.2.6. Gynecology
    • 4.2.2.7. Others
  • 4.2.3. By End-use
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Diagnostic Imaging Centers
    • 4.2.3.3. Others
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players*
  • 16.3.1. Wipro GE Healthcare Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Siemens Healthcare Private Limited
  • 16.3.3. Philips India Limited
  • 16.3.4. Toshiba Medical Systems India Pvt. Ltd.
  • 16.3.5. Hitachi Healthcare Manufacturing Ltd.
  • 16.3.6. Mindray Medical India Pvt. Ltd.
  • 16.3.7. Fujifilm India Pvt. Ltd.
  • 16.3.8. Hologic India Pvt. Ltd.
  • 16.3.9. Shanghai United Imaging Healthcare Co., LTD.
  • 16.3.10. Agfa Healthcare India Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Medical Imaging Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Medical Imaging Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Medical Imaging Market Share (%), By Product, FY2018-FY2032F
• Figure 4. India Medical Imaging Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Medical Imaging Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Medical Imaging Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024